Skip to main content
SpringerLink
Log in

Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Haase D, Germing U, Schanz J, Pfeilstocker M, Nosslinger T, Hildebrandt B, Kundgen A, Lubbert M, Kunzmann R, Giagounidis AA, Aul C, Trumper L, Krieger O, Stauder R, Muller TH, Wimazal F, Valent P, Fonatsch C, Steidl C (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110:4385–4395

    Article  PubMed  CAS  Google Scholar 

  2. Haase D (2008) Cytogenetic features in myelodysplastic syndromes. Ann Hematol 87:515–526

    Article  PubMed  Google Scholar 

  3. Steensma DP, List A (2005) Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc 80(5):681–698

    Article  PubMed  CAS  Google Scholar 

  4. List A, Dewald G, Bennett J, Giagounidis A, Raza A, Feldman E, Powell B, Greenberg P, Thomas D, Stone R, Reeder C, Wride K, Patin J, Schmidt M, Zeldis J, Knight R (2006) Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 355:1456–1465

    Article  PubMed  CAS  Google Scholar 

  5. Haferlach C, Bacher U, Tiu R, Maciejewski JP, List A (2008) Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing. Cancer Genet Cytogenet 187:101–111

    Article  PubMed  CAS  Google Scholar 

  6. Giagounidis A, Fenaux P, Mufti GJ, Muus P, Platzbecker U, Sanz G, Cripe L, Lilienfeld-Toal MV, Wells RA (2008) Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes. Ann Hematol 87:345–352

    Article  PubMed  CAS  Google Scholar 

  7. Giagounidis AA, Haase S, Heinsch M, Gohring G, Schlegelberger B, Aul C (2007) Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q) MDS patients with unexpected responses. Ann Hematol 86:133–137

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Spain

    Rita Coutinho, Mohammed Belkaid & Benet Nomdedeu

  2. Hematopathology Unit, Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain

    Dolors Costa, Ana Carrió, Concha Muñoz, Ana Vidal & Elias Campo

Authors
  1. Rita Coutinho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dolors Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana Carrió
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Concha Muñoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Vidal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohammed Belkaid
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elias Campo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Benet Nomdedeu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rita Coutinho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coutinho, R., Costa, D., Carrió, A. et al. Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series. Ann Hematol 89, 1069–1070 (2010). https://doi.org/10.1007/s00277-010-0932-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-0932-2

Keywords

Search

Navigation